What is credo?The Coalition to Reduce Disparities in Cardiovascular Outcomes, credo, is an ACCF initiative that provides cardiologists, nurses and other healthcare providers who treat or prevent CVD with the tools to assure optimal care for their increasingly diverse patients. By developing and disseminating evidence-based educational tools, credo seeks to help clinicians better serve all of their patients, regardless of race, ethnicity, gender, primary language, or other factors that may impact care. The tools available on this site do not reflect an endorsement by the ACCF or credo. To learn more about the criteria for listing information the credo website, click here. To share a resource on the credo website, please contact credo@acc.org. |
|
| credo Spotlight
New Spanish Language Cardiac Rehab Video
In collaboration with CardioSmart, credo has released a Spanish-language patient education video extolling the benefits of cardiac rehabilitation. Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, the National Alliance for Hispanic Health , the National Hispanic Cardiology Leadership Network and the Preventive Cardiovascular Nursing Association, the video highlights barriers to enrollment and completion of cardiac rehab and how patients overcome such barriers through vignettes of three cardiac rehabilitation program enrollees.
Visit CardioSmart to view the video. To request a DVD copy, email credo@acc.org.
|
| Why credo?
Read about the perspectives of leading clinicians on the value and importance of redressing health disparities in this feature.
- Martha Gulati, MD, MS, FACC - Associate Professor of Medicine in the Division of Cardiology at The Ohio State University
- Gordon Fung, MD, MPH, PhD, FACC - credo advisory board member and past President of the California chapter of ACC
- Marcus L. Williams, MD, FACC - President of the Association of Black Cardiologists, Inc.
- Diane Wallis, MD, FACC - Practicing cardiologist with Midwest Heart Specialists
|
| credo Sponsors
Advisory Board-Co-Chairs
Clyde W. Yancy, MD, MSc, FACC, FAHA, MACP Magerstadt Professor of Medicine Chief, Division of Cardiology Northwestern University, Feinberg School of Medicine Chicago, IL Disclosures Non-Commercial Interests: Officer, Director, Trustee or other Fiduciary Role of American Heart Association |
Tracy Y. Wang, MD, MHS, MSc, FACC Assistant Professor of Medicine Duke Clinical Research Institute Durham, NC Disclosures Consultant Fees/Honoraria from Johnson and Johnson; Daiichi Pharmaceutical Co, Ltd. Research Grants from Eli Lilly/Daiichi Sankyo Alliance; Schering Plough (now Merck); Bristol Myers Squibb; Heartscape, Inc.; The Medicines Company |
Hector O. Ventura, MD, FACC, FACP, FASH Co-Chair, National Hispanic Cardiologists Leadership Network Section Head, Cardiomyopathy and Heart Transplant Ochsner Heart and Vascular Institute New Orleans, LA Disclosures Speaker's Bureau for Actelion; Gilead |
|
Advisory Board Members |
Dee Baker Amos National Senior Manager, Health Equity & Multicultural Initiatives American Heart Association Dallas, TX Disclosures Nothing to disclose |
Paul N. Casale, MD, FACC Medical Director of Quality Chief, Division of Cardiology Medical Director of Cardiology Lancaster General Hospital Lancaster, PA Disclosures Nothing to disclose |
Paul S. Chan, MD, MSc Assistant Professor in Internal Medicine St. Luke's Mid America Heart and Vascular Institute Kansas City, MO Disclosures Nothing to disclose |
Marshall Chin, MD, MPH Director, Robert Wood Johnson Foundation (RWJF) Finding Answers: Disparities Research for Change National Program Office Professor of Medicine University of Chicago Chicago, IL Disclosures Research Grants from NIDDK; Agency for Healthcare Research and Quality; American Diabetes Association; Merck Company Foundation; The Commonwealth Fund; John A. Hartford Foundation; Robert Wood Johnson Foundation |
Adolph Falcón, MPP Senior Vice President National Alliance for Hispanic Health Washington, DC Disclosures Nothing to disclose |
Keith C. Ferdinand, MD, FACC, FAHA Adjunct Clinical Professor, Morehouse School of Medicine Clinical Professor, Emory University Chief Science Officer Association of Black Cardiologists (ABC), Inc. Atlanta, GA Disclosures Consultant Fees/Honoraria from AstraZeneca; Forest; Merck; Roche; Takeda. Research Grants from Daiichi Sankyo; Novartis |
Gordon L. Fung, MD, MPH, PhD, FACC Clinical Professor of Medicine, UCSF Director, UCSF Asian Heart & Vascular Center Former Governor, Northern CA, ACC Immediate Past President, California Chapter, ACC San Francisco, CA Disclosures Consultant Fees/Honoraria from Novartis; UCSF. Speaker's Bureau from Abbott Cardiovascular; Glaxo Smith Kline. Research Grants from Roche Pharmaceuticals. |
Tawara D. Goode, MA Assistant Professor & Director National Center for Cultural Competence Center for Child and Human Development Georgetown University Medical Center Washington, DC Disclosures Nothing to disclose |
Marcia Jackson, PhD President CME by Design Santee, SC Disclosures Consultant Fees/Honoraria from Medscape CME. Ownership Interest in CME by Design |
Christopher J.W.B. Leggett, MD, FACC Interventional Cardiologist Medical Associates of North Georgia Canton, GA Disclosures
|
Robert C. Like, MD, MS Professor and Director Center for Healthy Families and Cultural Diversity Department of Family Medicine and Community Health UMDNJ-Robert Wood Johnson Medical School New Brunswick, NJ Disclosures Consultant Fees/Honoraria from Medscape/UMDNJ Center for Continuing and Outreach Education Cultural Competency/Health Disparities CME and Educational Programs; Pfizer. Speaker's Bureau for Schering-Plough (now Merck) |
Laxmi Mehta, MD, FACC Clinical Director of the Women's Cardiovascular Health Program Associate Program Director for Education, Center for Women's Health Assistant Professor of Clinical Internal Medicine The Ohio State University Medical Center Columbus, OH Disclosures Nothing to disclose |
Aravinda Nanjundappa, MD, FACC, FSCAI, RVT Associate Professor of Medicine and Surgery West Virginia University Charleston, WV Disclosures Nothing to disclose |
Eric D. Peterson, MD, MPH, FACC, FAHA Professor of Medicine Associate Vice Chair for Quality Division of Cardiology, Duke University Medical Center Associate Director and Director of CV Research Duke Clinical Research Institute Durham, NC Disclosures Consultant Fees/Honoraria from Tethysbio; Astra-Zeneca. Research Grants from Merck/Schering; Johnson and Johnson; Eli Lilly; BMS/Sanofi Aventis |
Ileana L. Piña, MD, MPH, FACC, FAHA Chair of Science and Policy Workgroup of the National Hispanic Cardiologists Leadership Network Professor of Medicine Albert Einstein College of Medicine Associate Chief of Academic Affairs Montefiore Medical Center New York, NY Disclosures Consultant Fees/Honoraria from GE HealthCare; FDA |
Yabiz Sedghi, MD Chief Cardiology Fellow Ochsner Clinic Foundation New Orleans, LA Disclosures Nothing to disclose |
Joanna D. Sikkema, MSN, ARNP Director, Acute Care Nurse Practitioner Program, University of Miami Clinical Nurse Practitioner, Whole Health Management Miami, FL Disclosures Nothing to disclose |
Lisa M. Tate Chief Executive Officer WomenHeart: The National Coalition for Women with Heart Disease Washington, DC Disclosures
|
Krishnaswami Vijayaraghavan, MD, MS, FACC, FACP ACC Governor for Arizona Medical Director, CV Research and Education Scottsdale Healthcare Director, Heart Failure Program, Scottsdale CV Center Scottsdale, AZ Disclosures Consultant Fees/Honoraria from Daichii Sankyo; Gilead. Speaker's Bureau for Sanofi - Aventis; Novartis |
Mary Norine Walsh, MD, FACC Medical Director, Heart Failure and Cardiac Transplantation St. Vincent Heart Center of Indiana Indianapolis, IN Disclosures Consultant Fees/Honoraria from BioControl; Emerge; Medtronic; United Health Care |
Karol E. Watson. MD, PhD, FACC, FAHA Director, Center for Lipid and Hypertension Management Co-Director, Program in Preventive Cardiology Associate Professor of Medicine Division of Cardiology David Geffen School of Medicine at UCLA Los Angeles, CA Disclosures Consultant Fees/Honoraria from Astra Zeneca; Merck; Daiichi-Sankyo; Pfizer; Novartis |
|